# Biolytx Pharmaceuticals Corp — Form D

Biolytx Pharmaceuticals Corp of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-29. The offering totals $1.4M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2015-10-29
- Form: D
- Accession: 0001140361-15-038813
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.3M
- Remaining: $100K
- Minimum investment: $25K
- Investors: 12
- Date of first sale: 2015-10-16
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-250274

## Issuer

- Name: Biolytx Pharmaceuticals Corp
- CIK: 0001656890
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 800 RESEARCH PARKWAY, OKLAHOMA CITY, OK, 73104
- Phone: 405-271-6593

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| William A Hagstrom | Director | OKLAHOMA CITY, OK |
| H Anne Pereira | Director | OKLAHOMA CITY, OK |
| Douglas A Branch | Executive Officer | OKLAHOMA CITY, OK |
| H Anne Pereira | Executive Officer | OKLAHOMA CITY, OK |

## More

- [CIK 1656890 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1656890&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-15-038813.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.